vs
Side-by-side financial comparison of SELECT MEDICAL HOLDINGS CORP (SEM) and WEIBO Corp (WB). Click either name above to swap in a different company.
SELECT MEDICAL HOLDINGS CORP is the larger business by last-quarter revenue ($1.4B vs $1.3B, roughly 1.1× WEIBO Corp). WEIBO Corp runs the higher net margin — 35.7% vs 4.5%, a 31.2% gap on every dollar of revenue. Over the past eight quarters, WEIBO Corp's revenue compounded faster (22.6% CAGR vs 5.3%).
Select Medical is a healthcare company based in Pennsylvania. It owns long-term acute care and inpatient rehabilitation hospitals, as well as occupational health and physical therapy clinics. Select Medical is a subsidiary of Select Medical Holdings, which is listed on the New York Stock Exchange.
Weibo Corporation is a Chinese social network company known for the microblogging website Sina Weibo. It is based in Beijing, China.
SEM vs WB — Head-to-Head
Income Statement — Q1 FY2026 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.4B | $1.3B |
| Net Profit | $63.8M | $458.3M |
| Gross Margin | — | — |
| Operating Margin | 6.9% | 29.1% |
| Net Margin | 4.5% | 35.7% |
| Revenue YoY | 5.0% | — |
| Net Profit YoY | -14.7% | — |
| EPS (diluted) | $0.35 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.4B | — | ||
| Q4 25 | $1.4B | — | ||
| Q3 25 | $1.4B | $1.3B | ||
| Q2 25 | $1.3B | $841.7M | ||
| Q1 25 | $1.4B | $396.9M | ||
| Q4 24 | $1.3B | — | ||
| Q3 24 | $1.3B | $1.3B | ||
| Q2 24 | $1.3B | $833.4M |
| Q1 26 | $63.8M | — | ||
| Q4 25 | $20.2M | — | ||
| Q3 25 | $28.8M | $458.3M | ||
| Q2 25 | $40.6M | $234.8M | ||
| Q1 25 | $56.7M | $108.1M | ||
| Q4 24 | $-16.1M | — | ||
| Q3 24 | $55.6M | $297.4M | ||
| Q2 24 | $77.6M | $164.6M |
| Q1 26 | 6.9% | — | ||
| Q4 25 | 4.6% | — | ||
| Q3 25 | 5.4% | 29.1% | ||
| Q2 25 | 6.5% | 30.4% | ||
| Q1 25 | 8.3% | 27.8% | ||
| Q4 24 | 1.6% | — | ||
| Q3 24 | 4.3% | 29.0% | ||
| Q2 24 | 5.8% | 28.2% |
| Q1 26 | 4.5% | — | ||
| Q4 25 | 1.4% | — | ||
| Q3 25 | 2.1% | 35.7% | ||
| Q2 25 | 3.0% | 27.9% | ||
| Q1 25 | 4.2% | 27.2% | ||
| Q4 24 | -1.2% | — | ||
| Q3 24 | 4.4% | 22.9% | ||
| Q2 24 | 6.1% | 19.8% |
| Q1 26 | $0.35 | — | ||
| Q4 25 | $0.17 | — | ||
| Q3 25 | $0.23 | — | ||
| Q2 25 | $0.32 | — | ||
| Q1 25 | $0.44 | — | ||
| Q4 24 | $-0.12 | — | ||
| Q3 24 | $0.43 | — | ||
| Q2 24 | $0.60 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $25.7M | $1.1B |
| Total DebtLower is stronger | $1.8B | — |
| Stockholders' EquityBook value | $2.1B | $3.9B |
| Total Assets | $6.0B | $6.9B |
| Debt / EquityLower = less leverage | 0.88× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $25.7M | — | ||
| Q4 25 | $26.5M | — | ||
| Q3 25 | $60.1M | $1.1B | ||
| Q2 25 | $52.3M | $1.2B | ||
| Q1 25 | $53.2M | $1.2B | ||
| Q4 24 | $59.7M | — | ||
| Q3 24 | $191.5M | — | ||
| Q2 24 | $111.2M | $1.9B |
| Q1 26 | $1.8B | — | ||
| Q4 25 | $1.8B | — | ||
| Q3 25 | $1.7B | — | ||
| Q2 25 | $1.8B | — | ||
| Q1 25 | $1.8B | — | ||
| Q4 24 | $1.7B | — | ||
| Q3 24 | $3.1B | — | ||
| Q2 24 | $3.6B | — |
| Q1 26 | $2.1B | — | ||
| Q4 25 | $1.7B | — | ||
| Q3 25 | $1.7B | $3.9B | ||
| Q2 25 | $1.7B | $3.6B | ||
| Q1 25 | $1.7B | $3.5B | ||
| Q4 24 | $1.7B | — | ||
| Q3 24 | $1.9B | — | ||
| Q2 24 | $1.4B | $3.4B |
| Q1 26 | $6.0B | — | ||
| Q4 25 | $5.9B | — | ||
| Q3 25 | $5.7B | $6.9B | ||
| Q2 25 | $5.7B | $6.5B | ||
| Q1 25 | $5.7B | $6.7B | ||
| Q4 24 | $5.6B | — | ||
| Q3 24 | $8.0B | — | ||
| Q2 24 | $7.9B | $7.1B |
| Q1 26 | 0.88× | — | ||
| Q4 25 | 1.06× | — | ||
| Q3 25 | 1.03× | — | ||
| Q2 25 | 1.10× | — | ||
| Q1 25 | 1.03× | — | ||
| Q4 24 | 1.01× | — | ||
| Q3 24 | 1.62× | — | ||
| Q2 24 | 2.54× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SEM
Segment breakdown not available.
WB
| Income from operations | $373.2M | 29% |
| Shares used in computing diluted net income per share attributable to Weibos shareholders | $268.1M | 21% |
| Shares used in computing basic net income per share attributable to Weibos shareholders | $238.6M | 19% |
| Value-added services | $186.1M | 14% |
| Less: Income tax expenses | $113.2M | 9% |
| Investment related income, net | $45.0M | 4% |
| Product development | $16.7M | 1% |
| General and administrative | $10.6M | 1% |
| Sales and marketing | $7.1M | 1% |
| Accretion to redeemable non-controlling interests | $3.0M | 0% |
